Aadi Bioscience to Participate in Jefferies London Healthcare Conference

Rhea-AI Summary

Aadi Bioscience, Inc. will participate in the Jefferies London Healthcare Conference on November 14-16, 2023. The company's President and CEO, Dave Lennon, Ph.D., will participate in a fireside chat on November 14, 2023, at 8:30 am GMT. The fireside chat will be webcast live on the Aadi Bioscience website and will be available for replay for approximately 30 days.

LOS ANGELES, Nov. 6, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, announced today participation in the Jefferies London Healthcare Conference, taking place November 14-16, 2023, in London. Dave Lennon, Ph.D., President and CEO, will participate in a fireside chat on Tuesday, November 14, 2023, at 8:30 am GMT. 

The fireside chat will be webcast live on the IR pages of the Aadi Bioscience website and will be available for replay for approximately 30 days following each investor event.

About Aadi Bioscience, Inc.

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically defined cancers to bring transformational therapies to cancer patients with mTOR pathway driver alterations. Aadi received FDA approval and has commercialized FYARRO^® for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

Aadi has also initiated PRECISION1, a Phase 2 tumor-agnostic registration-intended trial in mTOR inhibitor-naïve malignant solid tumors harboring TSC1 or TSC2 inactivating alterations. More information on the Company's development pipeline is available on the Aadi website at www.aadibio.com and connect with us on Twitter and LinkedIn.

Contact:
Marcy Graham
IR@aadibio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-participate-in-jefferies-london-healthcare-conference-301978659.html

SOURCE Aadi Bioscience

FAQ

What is the upcoming event Aadi Bioscience is participating in?

Aadi Bioscience is participating in the Jefferies London Healthcare Conference.

Who will be representing Aadi Bioscience at the event?

Dave Lennon, Ph.D., the President and CEO of Aadi Bioscience, will be participating in a fireside chat.

When will the fireside chat take place?

The fireside chat will take place on November 14, 2023, at 8:30 am GMT.

Where can the fireside chat be accessed?

The fireside chat will be webcast live on the Aadi Bioscience website.

Will the fireside chat be available for replay?

Yes, the fireside chat will be available for replay for approximately 30 days following the event.